| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 8.2e-05 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -7.5e-05 | 1 |